Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Nov;38(2):610–619. doi: 10.1128/iai.38.2.610-619.1982

Infant rat model of attenuation for recombinant influenza viruses prepared from cold-adapted attenuated A/Ann Arbor/6/60.

M Ali, H F Maassab, R Jennings, C W Potter
PMCID: PMC347783  PMID: 6982866

Abstract

The pathogenicity of 6 wild-type influenza A viruses and 21 recombinant strains prepared from wild-type viruses and cold-adapted A/Ann Arbor/6/60 virus for infant rats was determined. Thus, the titers of virus present in the turbinates and lungs of virus-infected animals was measured serially for 5 days after intranasal infection, and the ability of virus strains to promote subsequent systemic bacterial infection by Haemophilus influenzae was measured at 48 h after virus infection. The results obtained were assessed with reference to the genetic constitution of the virus strains and to virus virulence for volunteers. The results showed that virulent viruses grew to relatively high titers in rat turbinates and significantly promoted systemic infection by H. influenzae. In contrast, attenuated strains grew to lower titers and failed to promote systemic H. influenzae infection. For the strains tested, the results showed clear differences for attenuated and virulent strains, and the model was a reliable indication of virulence for humans. Although the virulent strains tended to grow to higher titers in rat lungs than did attenuated strains, exceptions were found, and this measurement could not reliably discriminate virulent and attenuated virus strains. The results suggest that infant rats can be used to assess the virulence of cold-adapted recombinant influenza virus strains, and thus, they can facilitate the development of such strains for vaccine production.

Full text

PDF
610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abou-Donia H., Jennings R., Potter C. W. Growth of influenza A viruses in hamsters. Arch Virol. 1980;65(2):99–107. doi: 10.1007/BF01317321. [DOI] [PubMed] [Google Scholar]
  2. Beare A. S., Hall T. S. Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet. 1971 Dec 11;2(7737):1271–1273. doi: 10.1016/s0140-6736(71)90597-6. [DOI] [PubMed] [Google Scholar]
  3. Beare A. S., Hobson D., Reed S. E., Tyrrell D. A. A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet. 1968 Aug 24;2(7565):418–422. doi: 10.1016/s0140-6736(68)90463-7. [DOI] [PubMed] [Google Scholar]
  4. Beare A. S., Schild G. C., Craig J. W. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet. 1975 Oct 18;2(7938):729–732. doi: 10.1016/s0140-6736(75)90720-5. [DOI] [PubMed] [Google Scholar]
  5. DE ST GROTH S. F., WITHELL J., LAFFERTY K. J. An improved assay method for neutralizing antibodies against influenza viruses. J Hyg (Lond) 1958 Sep;56(3):415–426. doi: 10.1017/s0022172400037906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fenton R. J., Jennings R., Potter C. W. The serological response of experimental animals to inactivated whole and split influenza virus vaccines. J Biol Stand. 1977;5(3):217–229. doi: 10.1016/s0092-1157(77)80006-1. [DOI] [PubMed] [Google Scholar]
  7. Hara K., Beare A. S., Tyrrell D. A. Growth and pathogenicity of influenza viruses in organ cultures of ciliated epithelium. I. Experiments in ferret and human tissue. Arch Gesamte Virusforsch. 1974;44(3):227–236. doi: 10.1007/BF01240610. [DOI] [PubMed] [Google Scholar]
  8. Hrabar A., Vodopija I., André F. E., Mitchell J. R., Maassab H. F., Hennessy A. V., Davenport F. M. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers. Dev Biol Stand. 1977 Jun 1;39:53–60. [PubMed] [Google Scholar]
  9. Jennings R., Potter C. W., Teh C. Z., Mahmud M. I. The replication of type A influenza viruses in the infant rat: a marker for virus attenuation. J Gen Virol. 1980 Aug;49(2):343–354. doi: 10.1099/0022-1317-49-2-343. [DOI] [PubMed] [Google Scholar]
  10. Lobmann M., Delem A., Peetermans J., Huygelen C. Laboratory characteristics of an attenuated influenza type A (H3N2) virus ('Alice' strain). J Hyg (Lond) 1976 Oct;77(2):181–188. doi: 10.1017/s0022172400024608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Maassab H. F., Francis T., Jr, Davenport F. M., Hennessy A. V., Minuse E., Anderson G. Laboratory and clinical characteristics of attenuated strains of influenza virus. Bull World Health Organ. 1969;41(3):589–594. [PMC free article] [PubMed] [Google Scholar]
  12. Mackenzie J. S. The potential advantages and requirements of live attenuated influenza virus vaccines. Aust N Z J Med. 1977 Aug;7(4):431–437. doi: 10.1111/j.1445-5994.1977.tb04412.x. [DOI] [PubMed] [Google Scholar]
  13. Mahmud M. I., Maassab H. F., Jennings R., Potter C. W. Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent. Arch Virol. 1979;61(3):207–216. doi: 10.1007/BF01318055. [DOI] [PubMed] [Google Scholar]
  14. McCahon D., Beare A. S., Stealey V. The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2). Postgrad Med J. 1976 Jun;52(608):389–394. doi: 10.1136/pgmj.52.608.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McLaren C., Potter C. W., Jennings R. Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens. Med Microbiol Immunol. 1974;160(1):33–45. doi: 10.1007/BF02124341. [DOI] [PubMed] [Google Scholar]
  16. Michaels R. H., Mahmud M. I., Coup A. J., Jennings R., Potter C. W. Influenza virus infection in newborn rats: a possible marker of attenuation for man. J Med Virol. 1978;2(3):253–264. doi: 10.1002/jmv.1890020309. [DOI] [PubMed] [Google Scholar]
  17. Mortiz A. J., Kunz C., Hofman H., Liehl E., Reeve P., Maassab H. F. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis. 1980 Dec;142(6):857–860. doi: 10.1093/infdis/142.6.857. [DOI] [PubMed] [Google Scholar]
  18. Mostow S. R., Tyrrell D. A. Detection of attenuation of recombinant influenza viruses in vitro. Lancet. 1972 Jul 15;2(7768):116–117. doi: 10.1016/s0140-6736(72)91599-1. [DOI] [PubMed] [Google Scholar]
  19. Mostow S. R., Tyrrell D. A. The behaviour in vitro of attenuated recombinant influenza viruses. Arch Gesamte Virusforsch. 1973;43(4):385–392. doi: 10.1007/BF01556156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Murphy B. R., Chalhub E. G., Nusinoff S. R., Chanock R. M. Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man. J Infect Dis. 1972 Aug;126(2):170–178. doi: 10.1093/infdis/126.2.170. [DOI] [PubMed] [Google Scholar]
  21. Murphy B. R., Chanock R. M., Levine M. M., van Blerk G. A., Berquist E. J., Douglas R. G., Betts R. F., Couch R. B., Cate T. R., Jr Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Infect Immun. 1979 Feb;23(2):249–252. doi: 10.1128/iai.23.2.249-252.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Murphy B. R., Holley H. P., Jr, Berquist E. J., Levine M. M., Spring S. B., Maassab H. F., Kendal A. P., Chanock R. M. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun. 1979 Feb;23(2):253–259. doi: 10.1128/iai.23.2.253-259.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murphy B. R., Wood F. T., Massicot J. G., Chanock R. M. Temperature-sensitive mutants of influenza virus. XVI. Transfer of the two ts lesions present in the Udorn/72-ts-1A2 donor virus to the Victoria/3/75 wild-type virus. Virology. 1978 Jul 15;88(2):244–251. doi: 10.1016/0042-6822(78)90281-7. [DOI] [PubMed] [Google Scholar]
  24. Spring S. B., Maassab H. F., Kendal A. P., Murphy B. R., Chanock R. M. Cold-adapted variants of influenza virus A. I. Comparison of the genetic properties of ts mutants and five cold-adapted variants of influenza virus A. Virology. 1977 Mar;77(1):337–343. doi: 10.1016/0042-6822(77)90430-5. [DOI] [PubMed] [Google Scholar]
  25. Teh C., Jennings R., Potter C. W. Influenza virus infection of newborn rats: virulence of recombinant strains prepared from influenza virus strain A/Okuda/57. J Med Microbiol. 1980 May;13(2):297–306. doi: 10.1099/00222615-13-2-297. [DOI] [PubMed] [Google Scholar]
  26. Toms G. L., Bird R. A., Kingsman S. M., Sweet C., Smith H. The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man. Br J Exp Pathol. 1976 Feb;57(1):37–48. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES